# Malladi Drugs & Pharmaceuticals Ltd. – FDA Inspection, Aug 4, 2017

Source: https://www.keypedia.com/records/fda_inspections/malladi-drugs-pharmaceuticals-ltd/4fa99313-3ee2-4876-bc4d-03a16fca7105
Source feed: FDA_Inspections

> FDA inspection 1022300 of Malladi Drugs & Pharmaceuticals Ltd., August 04, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1022300
- Company Name: Malladi Drugs & Pharmaceuticals Ltd.
- Inspection Date: 2017-08-04
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1331272 - 2026-07-03
- FDA Inspection 1119575 - 2020-01-31
- [FDA Inspection 1070896 - 2018-10-09](https://www.keypedia.com/records/fda_inspections/malladi-drugs-pharmaceuticals-ltd/6a897c8b-75fd-4501-80ca-226f799dafa4)
- FDA Inspection 910002 - 2014-12-19

## Related Officers

- [Saleem A. Akhtar](https://www.keypedia.com/people/saleem-a-akhtar/1ea49212-bea5-4d43-bd0a-cdede4d3b1cf)

Company: https://www.keypedia.com/companies/malladi-drugs-pharmaceuticals-ltd/8731c6b8-8b3a-4cb6-a434-01c1a5020576

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c